Articles in News
You can’t imagine our surprise today when we saw that Pfizer has announced that it will license injectable and solid dosage forms from Aurobindo. We wrote about Pfizer’s new generics strategy on monday, but we …
“If you can’t beat them, join them”. So goes the old saying that is proving more true day-by-day in the pharma industry. A few years ago it would have been unthinkable that Pfizer, the world’s …
Two very positive announcements were made last week by Andrew Witty, chief executive of Galxo SmithKline. The first covers the price of medicines in developing nations which he said Glaxo would cap at no more …
Even as patents on huge blockbuster drugs are still expiring, the smart generics companies have been preparing for some time for a future in which there are fewer and fewer syntehsized molecules to copy and …
Following the death of Mr. Merckle, the sale of his empire continues at a swift pace. The Independent is reporting that Phoenix UK, with a turnover of €1.2bn and controlling 15 per cent of the …
The first generics casualty of the financial crisis was Ratiopharm which is now being sold my the Merckle family to make up for their recent stock market losses. Now Actavis, the fifth largest generics company …
We were shocked today to read that the owner of both Ratiopharm, one of Europe’s largest generics companies and Phoenix PharmaHandel, Europe’s 2nd largest drug distributor, has committed suicide as a result of having lost …
You know the big-pharma club is in trouble when most of its members are jumping ship from fighting against generics to producing generics themselves. Novartis, GSK, Sanofi and Daiichi are just a few examples of …
Despite all the positive awareness-building campaigns run by generics companies all over the world, there still remains a persistent stigma amongst patients and even some doctors that generic medicines are in some way different or …
Adolf Merckle, the owner of the privately held Ratiopharm, one of the worlds largest generics manufacturers, has gotten himself into a whole world of trouble over his attempts to short-sell Volkswagen shares recently. His play …

